Buscar resultados de ensayos clínicos

Patrocinado por

Hypereosinophilic Syndrome - 14 Studies Found

Estado Estudiar
Terminated Nombre del estudio: A Study to Determine the Safety and Efficacy of Imatinib Mesylate in Patients With Idiopathic Hypereosinophilic Syndrome
Condición: Hypereosinophilic Syndrome
Fecha: 2005-09-13
Intervenciones: Drug: imatinib mesylate Other Name: Gleevec/Glivec
Terminated Nombre del estudio: Open-Label Extension Of Intravenous Mepolizumab In Patients With Hypereosinophilic Syndrome
Condición: Hypereosinophilic Syndrome
Fecha: 2004-11-22
Intervenciones: Drug: mepolizumab Study Drug
Completed Nombre del estudio: Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES)
Condición: Hypereosinophilic Syndrome
Fecha: 2016-07-14
Intervenciones:
  • Drug: Mepolizumab 300 mg Mepol
Active, not recruiting Nombre del estudio: Identification of New Markers in the Hypereosinophilic Syndrome
Condición: Hypereosinophilic Syndrome
Fecha: 2012-10-22
Intervenciones: Biological: biologie sample comparison of biomarkers between HES, HE biomarkers data and control arms
Active, not recruiting Nombre del estudio: Study to Evaluate Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects With Hypereosinophilic Syndrome
Condición: Hypereosinophilic Syndrome
Fecha: 2014-03-14
Intervenciones: Drug: Dexpramipexole Dexpramipexole (KNS 760704) is a synthetic amino-benzothiazole developed for use in
Completed Nombre del estudio: Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES)
Condición:
  • Hypereosinophilia
  • Hypereosinophilic Syndrome

Fecha: 2004-07-07
Intervenciones: Drug: mepolizumab
Available Nombre del estudio: This Record Contains Information About the Mepolizumab Compassionate Use Product Activities: 104317: An Open-Label Compassionate Use and Long-Term Access Study of Mepolizumab in HES 201956: A Long-term Access Programme for Subjects With Severe Asthma
Condición: Hypereosinophilic Syndrome
Fecha: 2005-10-25
Intervenciones: Drug: Mepolizumab open label investigational product
Completed Nombre del estudio: Efficacy of Imatinib Mesylate in Hypereosinophilic Syndromes
Condición:
  • Hypereosinophilic Syndrome
  • Chronic Eosinophilic Leukemia
    • <
    Fecha: 2008-11-06
    Intervenciones: Drug: Imatinib Patients received oral imatinib 100 mg/d; in case of unsatisfactory response (less than c
Completed Nombre del estudio: Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias
Condición:
  • Hypereosinophilic Syndrome
  • Chronic Eosinophilic Leukemia (CEL)<
    Fecha: 2006-01-12
    Intervenciones: Drug: STI571
Completed Nombre del estudio: Steroid Treatment for Hypereosinophilic Syndrome
Condición: Hypereosinophilia
Fecha: 2012-02-01
Intervenciones: Drug: Corticosteroids
Next >>>